Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Colin Love currently holds 777,345 shares of Replimune Group, Inc. (REPL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Colin Love has been a net seller of REPL stock. They have purchased $0 and sold $13.3M worth of shares.
Colin Love's most recent insider trade was on May 16, 2024, when they sold 17,615 shares at $6.47 per share.
Colin Love serves as Executive at Replimune Group, Inc. (REPL). They have executed 46 insider transactions totaling $13.3M over their tenure at the company.
Colin Love holds the position of Executive at Replimune Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Colin Love has shown a selling trading pattern, with $0 in total purchases and $13.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Colin Love was on Jul 15, 2021, when they sold $960.6K worth of REPL shares. This transaction involved 30,000 shares at $32.02 per share.
Colin Love currently owns 777,345 shares of Replimune Group, Inc. (REPL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Colin Love's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Colin Love has 46 Form 4 filings on record as an insider at Replimune Group, Inc..
Set alerts for Colin Love and 40,000+ other insiders.